Galmed Pharmaceuticals Ltd (GLMD)
0.3944
+0.01
(+2.74%)
USD |
NASDAQ |
May 16, 16:00
0.3944
0.00 (0.00%)
After-Hours: 20:00
Galmed Pharmaceuticals Enterprise Value: -10.33M for May 15, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 15, 2024 | -10.33M |
| May 14, 2024 | -10.22M |
| May 13, 2024 | -10.31M |
| May 10, 2024 | -10.25M |
| May 09, 2024 | -10.15M |
| May 08, 2024 | -10.30M |
| May 07, 2024 | -10.19M |
| May 06, 2024 | -10.12M |
| May 03, 2024 | -10.31M |
| May 02, 2024 | -10.33M |
| May 01, 2024 | -10.32M |
| April 30, 2024 | -10.53M |
| April 29, 2024 | -10.36M |
| April 26, 2024 | -10.29M |
| April 25, 2024 | -10.28M |
| April 24, 2024 | -10.24M |
| April 23, 2024 | -10.47M |
| April 22, 2024 | -10.45M |
| April 19, 2024 | -10.40M |
| April 18, 2024 | -10.37M |
| April 17, 2024 | -10.43M |
| April 16, 2024 | -10.51M |
| April 15, 2024 | -10.38M |
| April 12, 2024 | -10.12M |
| April 11, 2024 | -10.12M |
| Date | Value |
|---|---|
| April 10, 2024 | -10.24M |
| April 09, 2024 | -10.31M |
| April 08, 2024 | -10.26M |
| April 05, 2024 | -10.60M |
| April 04, 2024 | -10.66M |
| April 03, 2024 | -10.68M |
| April 02, 2024 | -10.70M |
| April 01, 2024 | -10.74M |
| March 28, 2024 | -10.56M |
| March 27, 2024 | -10.66M |
| March 26, 2024 | -11.03M |
| March 25, 2024 | -11.03M |
| March 22, 2024 | -11.07M |
| March 21, 2024 | -11.05M |
| March 20, 2024 | -11.10M |
| March 19, 2024 | -11.06M |
| March 18, 2024 | -11.07M |
| March 15, 2024 | -11.10M |
| March 14, 2024 | -10.88M |
| March 13, 2024 | -10.83M |
| March 12, 2024 | -10.83M |
| March 11, 2024 | -10.78M |
| March 08, 2024 | -10.72M |
| March 07, 2024 | -10.72M |
| March 06, 2024 | -10.78M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-17.69M
Minimum
Jun 17 2022
69.10M
Maximum
Jan 07 2020
11.61M
Average
7.682M
Median
Enterprise Value Benchmarks
| Compugen Ltd | 147.18M |
| Pluri Inc | 33.08M |
| BioLine Rx Ltd | 16.10M |
| Can Fite Biofarma Ltd | 1.308M |
| BiomX Inc | 15.36M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.016M |
| Total Expenses (Quarterly) | 2.151M |
| EPS Diluted (Quarterly) | -0.98 |
| Earnings Yield | -826.6% |
| Normalized Earnings Yield | -2510.14 |